Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Research

ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes

Cite this Article

To cite this article please use the text below.

Joshi Amit, Pande Nikhil, Noronha Vanita, Patil Vijay, Kumar Rajiv, Chougule Anuradha, Vaishakhi Trivedi, Janu Amit, Mahajan Abhishek and Prabhash Kumar (2019) ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes ecancer 13 900



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation